ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Pak to seek loan from Russia for 'strategic' pipeline project

Islamabad [Pakistan], October 25 (ANI): Four-day talks between Pakistan and the Russian Federation are scheduled to commence on October 25 and are expected to last till October 29. The talks aim to finalise the shareholdings agreement on a strategic project, reported The News citing an official document.

ANI Oct 25, 2021 08:54 IST googleads

Representative Image

Islamabad [Pakistan], October 25 (ANI): Four-day talks between Pakistan and the Russian Federation are scheduled to commence on October 25 and are expected to last till October 29. The talks aim to finalise the shareholdings agreement on a strategic project, reported The News citing an official document.
According to the document, the agreement will be on the strategic project of the Pakistan Stream Gas Pipeline.
Citing the amended Inter-Governmental Agreement (IGA), the newspaper reported that 74 per cent of the shareholding will belong to Pakistan and 26 per cent to Russia. Given that the agreement is reached and duly signed, a pipeline of reportedly 1,040 kilometres in length will be laid down from Karachi to Kasur in Punjab.
The newspaper reported the confirmation of the talks citing confirmation by Secretary Petroleum.
The Imran Khan government has planned on taking debt from Russian EXIM bank and several other financial projects for financing the project. However, due to the constraints of the outflow of USD from the reserves at one go, the government is looking to borrow a loan from the Russian bank which will be used to buy pipelines and compressors, reported The News citing the sources.
Moreover, Pakistan had asked Russia to shoot up the shareholding from the existing 26 per cent to49 per cent, which implies that the Imran Khan government is short of the amount required to finance its own shareholding of the proposed 74 per cent, according to the newspaper.
The Russian financing of merely 26 per cent reflects the seriousness of the country towards investment in Pakistan and its economy. (ANI)

Get the App

What to Read Next

Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Asia

Factoring domestic needs as B'desh, others seek diesel supply

Factoring domestic needs as B'desh, others seek diesel supply

"India is a major exporter of petroleum products, especially to our neighbourhood. We have been supplying diesel to Bangladesh through waterways, rail and the India-Bangladesh Friendship Pipeline in partnership with Bangladesh Petroleum Corporation. Diesel exports to Bangladesh have continued since then," he said.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.